Neuro-OncologyThe purpose of this review is to provide a suf ciently detailed perspective on epidemiologic studies of primary brain tumors to encourage multidisciplinary etiologic and prognostic studies among surgeons, neuro-oncologists, epidemiologists, and molecular scientists. Molecular tumor markers that predict survival and treatment response are being identi ed with hope of even greater gains in this area from emerging array technologies. Regarding risk factors, studies of inherited susceptibility and constitutive polymorphisms in genes pertinent to carcinogenesis (for example, DNA repair and detoxi cation genes and mutagen sensitivity) have revealed provocative ndings. Inverse associations of the history of allergies with glioma risk observed in 3 large studies and reports of inverse associations of glioma with common infections suggest a possible role of immune factors in glioma genesis or progression. Studies continue to suggest that brain tumors might result from workplace, dietary, and other personal and residential exposures, but studies of cell phone use and power frequency electromagnetic elds have found little to support a causal connection with brain tumors; caveats remain. The only proven causes of brain tumors (that is, rare hereditary syndromes, therapeutic radiation, and immune suppression giving rise to brain lymphomas) account for a small proportion of cases. Progress in understanding primary brain tumors might result from studies of well-de ned histologic and molecular tumor types incorporating assessment of potentially relevant information on subject susceptibility and environmental and noninherited endogenous factors (viruses, radiation, and carcinogenic or protective chemical exposures through diet, workplace, oxidative metabolism, or other sources). Such studies will require the cooperation of researchers from many disciplines. Neuro-Oncology 4, 278-299, 2002 (Posted to Neuro-Oncology [serial online], Doc. 02-011, August 27, 2002 P rimary malignant or benign brain tumors were estimated to be newly diagnosed in about 35,519 Americans in 2001 (CBTRUS, 2000. Epidemiologic studies enhance our understanding of this heterogeneous group of diseases in 2 ways. Descriptive studies characterize the incidence of brain tumors and the mortality and survival rates associated with them with respect to histologic tumor type and demographic characteristics of patients affected, such as their age, sex, and geographic region. Analytic epidemiologic studies either compare the risk of brain tumors in people with and without certain characteristics (cohort studies) or compare the histories of people with and without brain tumors (case-control studies) to provide information on a wide range of possible risk factors, including diet, smoking, alcohol, occupation and industry, exposure to ionizing or nonionizing radiation, infections, allergies, head trauma, family history, and inherited polymorphisms in genes related to carcinogen metabolism, oxidative metabolism, and DNA repair. Because of the relative ra...